GSK3 acts as a switch for transcriptional programs in a model of low-grade gliomagenesis
Abstract Mutations in isocitrate dehydrogenase (IDH)1/2 are defining drivers of low-grade gliomagenesis. However, mutant IDH alone is not sufficient for malignant transformation, and additional events are required for the development of low-grade glioma. While specific genetic lesions have been iden...
Saved in:
| Main Authors: | Marilin S Koch, Minh Deo, Lena-Marie Schmitt, Michael S Hoetker, Şevin Turcan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | Acta Neuropathologica Communications |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40478-025-02006-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Integrative analysis reveals key molecular mechanisms and prognostic model for Ethylnitrosourea-induced gliomagenesis
by: Bo Tan, et al.
Published: (2025-04-01) -
ROLE OF GSK-3 IN Wnt/β-CATENIN SIGNALING PATHWAY IN OBESITY
by: A. S. Kulakova, et al.
Published: (2021-10-01) -
IDH1(R132H) Immunoexpression in Glioma
by: Nyan Saeed Omer, et al.
Published: (2023-03-01) -
Molecular Biomarkers of Glioma
by: Punsasi Rajakaruna, et al.
Published: (2025-05-01) -
Ras-AKT signaling represses the phosphorylation of histone H1.5 at threonine 10 via GSK3 to promote the progression of glioma
by: Ben Sang, et al.
Published: (2019-12-01)